Your browser doesn't support javascript.
loading
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience.
Pan, Hong; Tao, Jing; Qian, Mengjia; Zhou, Wenbin; Qian, Yi; Xie, Hui; Jing, Shengqi; Xu, Tingyu; Zhang, Xin; Dai, Zuolei; You, Mingliang; Liu, Yun; Liu, Xiaoan; Wang, Shui.
Affiliation
  • Pan H; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Tao J; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Qian M; Department of General Surgery, The Fourth Affiliated Hospital of Nanjing Medical University (Nanjing Pukou Hospital), Nanjing 210031, China.
  • Zhou W; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Qian Y; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Xie H; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Jing S; Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Xu T; Department of Information, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Zhang X; Institute of Medical Informatics and Management, Nanjing Medical University, Nanjing 210029, China.
  • Dai Z; Department of Information, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • You M; Institute of Medical Informatics and Management, Nanjing Medical University, Nanjing 210029, China.
  • Liu Y; Department of Information, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Liu X; Institute of Medical Informatics and Management, Nanjing Medical University, Nanjing 210029, China.
  • Wang S; Department of Information, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
Transl Cancer Res ; 8(2): 389-401, 2019 Apr.
Article in En | MEDLINE | ID: mdl-35116771
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Transl Cancer Res Year: 2019 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Transl Cancer Res Year: 2019 Document type: Article Affiliation country: China Country of publication: China